Antibody Drug Safety: The Importance of Early Specificity Testing
Tuesday, 17 September 2024, 22:35
Significance of Early Specificity Testing in Antibody Drugs
Antibody drug safety is a primary concern in pharmaceutical research. Emerging evidence indicates that nearly one-third of antibody-based drugs may show nonspecific interactions with cell membranes and proteins in the proteome. This alarming statistic highlights the necessity for rigorous early specificity testing.
Key Findings from Recent Research
- Integral Molecular leads in antibody discovery, providing valuable insights.
- Studies published in mAbs reveal significant risks in current antibody drugs.
- Early testing technologies evolve, promising improved therapeutic outcomes.
This reinforces the importance of innovative research techniques and technologies in antibody development.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.